Concepedia

111In-Bn-DTPA-nimotuzumab with/without modification with nuclear translocation sequence (NLS) peptides: an Auger electron-emitting radioimmunotherapeutic agent for EGFR-positive and trastuzumab (Herceptin)-resistant breast cancer

Humphrey Fonge, Zhongli Cai, Jeffrey V. Leyton, Ilia Tikhomirov, Susan J. Done, Raymond M. Reilly

Breast Cancer Research and Treatment · 2012 · 55 citations · 26 references

References

26

American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer

Antonio C. Wolff, M. Elizabeth H. Hammond, Jared N. Schwartz et al. · Journal of Clinical Oncology · 2006 · 4.5K citations · Full text

Medicine, Oncology, Pathology +11

HER2 Amplification Ratios by Fluorescence In Situ Hybridization and Correlation with Immunohistochemistry in a Cohort of 6556 Breast Cancer Tissues

Marilyn A. Owens, Bruce Horten, Moacyr M. Da Silva · Clinical Breast Cancer · 2004 · 653 citations

Medicine, Molecular Biology, Oncology +14

Characterization of a Novel Tripartite Nuclear Localization Sequence in the EGFR Family

Sheng-Chieh Hsu, Mien‐Chie Hung · Journal of Biological Chemistry · 2007 · 260 citations · Full text

Life Sciences, Molecular Biology, Oncology +11

Nuclear‐cytoplasmic transport of EGFR involves receptor endocytosis, importin β1 and CRM1

Hui‐Wen Lo, Mohamed Ali‐Seyed, Yadi Wu et al. · Journal of Cellular Biochemistry · 2006 · 240 citations

Life Sciences, Cell Biology, Oncology +17

Clinical trials of Herceptin® (trastuzumab)

José Baselga · European Journal of Cancer · 2001 · 225 citations

Medicine, Immunology, Pharmacology +8